Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.67NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.5.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.67NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FL.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.2.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.2.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.2.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.5.88EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.88NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.88NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.5.88NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.88NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.16NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.16NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.5.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.16NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CM.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CM.10NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CM.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.10NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.2.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.25NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.25NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.25NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.42EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.42NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.42NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.42NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BQ.1.1.69NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.69NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.69NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-2822.66China
BQ.1.1.70NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.70NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.70NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BN.1.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.5.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used